Advanced Search:
Equity Index Forex Crypto Commodity

LLY - Eli Lilly and Company

$751.64  -7.95 (-1.05%)

Updated: 03:18 May 5, 2024 EST

Next Hour's AI Forecast

99.66%

Avg. Accuracy (AI)

$771.62

Next Session's AI Forecast

96.13%

Avg. Accuracy (AI)

$781.12

Next Week's AI Forecast

83.33%

Trend's Accuracy (AI)

$773.94

Eli Lilly and Company's Position Within the Drug Manufacturers—General Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

ELI LILLY AND COMPANY - HISTORICAL DATA 6M

  • Last price

    $ 751.64

  • Daily change

    $ -7.95

  • Previous Close

    $ 759.59

  • Last Updated

    03:18 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-0.43 -0.06 0.08 0.19 0.24

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
3.31 1.64 1.29 1.23 1.25

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
100% 74.36% 74.36% 62.02%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
772.23 3.24% 748.02 -1.43% 758.88 12.02% 677.44

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.58 66.22 1.3 36.71

Eli Lilly and Company Technical Analysis News

Eli Lilly and Company

Lilly Corporate Center
Indianapolis, IN 46285
United States
317 276 2000
https://www.lilly.com

Sectors: Healthcare
Industry: Drug Manufacturers—General
F. Time Employees: 43000
Description

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Corporate Governance

Eli Lilly and Company’s ISS Governance QualityScore as of May 1, 2024 is 5. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 9; Compensation: 1.

ELI LILLY AND COMPANY'S HOLDERS RANK

List of holders with stock participation in Eli Lilly and Company.

Holder Rank Holder Shares Date Reported % Out Value